2018年7月18日星期三

Overview of the Physical State of Proteins Within Cells

The word protein comes from the Greek word proteios, meaning primary. And, indeed, proteins are of primary importance in the study of cell function. It is difficult to imagine a cellular function not linked with proteins. Almost all biochemical catalysis is carried out by protein enzymes. Proteins participate in gene regulation, transcription, and translation. Intracellular filaments give shape to a cell while extracellular proteins hold cells together to form organs. Proteins transport other molecules, such as oxygen, to tissues. Antibody molecules contribute to host defense against infections. Protein hormones relay information between cells. Moreover, protein machines, such as actin-myosin complexes, can perform useful work including cell movement. Thus, studying proteins is a prerequisite in understanding cell structure and function.

The physical characterization of proteins began well over 150 years ago with Mulder’s characterization of the atomic composition of proteins. In the latter half of the nineteenth century Hoppe-Seyler (1864) crystallized hemoglobin and Kühn (1876) purified trypsin. A variety of physical methods have been developed over the years to increase convenience and precision in the characterization and isolation of proteins. These include ultracentrifugation, chromatography, electrophoresis, and others. In many instances our understanding of cell proteins parallels the introduction and use of new techniques to examine their structure and function.

All proteins are constructed as a linear sequence(s) of various numbers and combinations of ∼20 α-amino acids joined by peptide bonds to form structures from thousands to millions of daltons in size. Proteins are the most complex and heterogeneous molecules found in cells, where they account for >50% of the dry weight of cells and ∼75% of tissues. Proteins can be classified into three broad groups: globular, fibrous, and transmembrane (Table 1, Figure 1). Globular proteins are, by definition, globe-shaped, although in practice they can be spherical or ellipsoidal. Globular proteins are generally soluble in aqueous environments. Examples of globular proteins are hemoglobin, serum albumin, and most enzymes. Fibrous proteins are elongated linear molecules that are generally insoluble in water and resist applied stresses and strains. Collagen is a physically tough molecule of connective tissue. Just as collagen gives strength to connective tissues, intermediate filaments linked to desmosomes give strength to cells in tissues. The third general class of proteins, transmembrane proteins, contain a hydrophobic sequence buried within the membrane. These protein categories are not mutually exclusive. For example, the nominally fibrous intermediate filament proteins also have globular domains. Similarly, transmembrane proteins almost always possess globular domains. Thus, these definitions serve as a useful guide but should not be rigidly applied.

Figure 1 General classifications of proteins.


In these schematic representations of globular, fibrous, and transmembrane proteins, hydrophobic regions are shaded. Note that the disposition of hydrophobic residues often reflects the protein class.

Table 1 Broad Classifications for Proteins


A key physical feature of proteins is their hydropathy pattern (i.e., the distribution of hydrophobic and hydrophilic amino acid residues). Indeed, hydrophobic interactions provide the primary net free energy required for protein folding. Figure 1 illustrates the disposition of hydrophobic amino acids in proteins. In an intact globular protein, hydrophobic amino acids are generally shielded from the aqueous environment by coalescing at the center of the molecule, with the more hydrophilic residues exposed at its surface. However, the linear arrangement of hydrophobic residues fluctuates in an apparently random fashion. The α helices within globular proteins may express a hydrophobic face oriented toward the center of the protein. Within these helices hydrophobic residues are nonrandomly positioned every three or four amino acids to yield a hydrophobic face. For coiled-coil α helix–containing fibrous proteins, such as tropomyosin and α-keratin, hydrophobic residues at periodic intervals allow close van der Waals contact of the chains and potentiate assembly as hydrophobic residues are removed from the aqueous environment. Secondarily, regularly spaced charged groups can also contribute to the shape of fibrous proteins. Transmembrane proteins provide a rather different physical arrangement of hydrophobic residues in which hydrophobic residues are collected primarily into a series of amino acids that is embedded within a cell membrane. One important means of analyzing the hydropathy of a sequenced protein is a hydropathy plot. In this method, each amino acid residue is assigned a hydropathy value, an ad hoc measure that largely reflects its relative aqueous solubility; these values are plotted after being averaged. The successful interpretation of hydropathy plots depends on the parameters chosen for averaging. The parameters are the number of residues averaged (amino acid interval or “window”) and how many amino acids are skipped when calculating the next average (step size). Using this approach with a window of ∼10 residues, it is often possible to find the positions of hydrophobic residues coalescing near the interior of globular proteins. The method is particularly useful in predicting transmembrane domains of proteins, generally with a window of ∼20 amino acids. To detect the repetitious pattern of coiled-coil fibrous proteins, however, windows smaller than the repeat length would be required.

2018年7月17日星期二

Fasting Activates Fatty Acid Oxidation to Enhance Intestinal Stem Cell Function during Homeostasis and Aging

Content introduction:

  • Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

  • Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer

  • A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment

  • Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression

  • Fasting Activates Fatty Acid Oxidation to Enhance Intestinal Stem Cell Function during Homeostasis and Aging


1. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
Combination immune checkpoint blockade has demonstrated promising benefit in lung cancer, but predictors of response to combination therapy are unknown. Using whole-exome sequencing to examine non-small-cell lung cancer (NSCLC) treated with PD-1 plus CTLA-4 blockade, Matthew D. Hellmann at Memorial Sloan Kettering Cancer Center in New York, USA and his colleagues found that high tumor mutation burden (TMB) predicted improved objective response, durable benefit, and progression-free survival. TMB was independent of PD-L1 expression and the strongest feature associated with efficacy in multivariable analysis. The low response rate in TMB low NSCLCs demonstrates that combination immunotherapy does not overcome the negative predictive impact of low TMB. This study demonstrates the association between TMB and benefit to combination immunotherapy in NSCLC. TMB should be incorporated in future trials examining PD-(L)1 with CTLA-4 blockade in NSCLC.

Read more, please click https://www.cell.com/cancer-cell/fulltext/S1535-6108(18)30123-5

2. Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
Durable responses and encouraging survival have been demonstrated with immune checkpoint inhibitors in small-cell lung cancer (SCLC), but predictive markers are unknown. Matthew D. Hellmann at Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy in New York, USA and his colleagues used whole exome sequencing to evaluate the impact of tumor mutational burden on efficacy of nivolumab monotherapy or combined with ipilimumab in patients with SCLC from the nonrandomized or randomized cohorts of CheckMate 032. Patients received nivolumab (3 mg/kg every 2 weeks) or nivolumab plus ipilimumab (1 mg/kg plus 3 mg/kg every 3 weeks for four cycles, followed by nivolumab 3 mg/kg every 2 weeks). Efficacy of nivolumab ± ipilimumab was enhanced in patients with high tumor mutational burden. Nivolumab plus ipilimumab appeared to provide a greater clinical benefit than nivolumab monotherapy in the high tumor mutational burden tertile.

Read more, please click https://www.cell.com/cancer-cell/fulltext/S1535-6108(18)30172-7

3. A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment
Gliomas comprise heterogeneous malignant glial and stromal cells. While blood vessel co-option is a potential mechanism to escape anti-angiogenic therapy, the relevance of glial phenotype in this process is unclear. Amelie Griveau at University of California San Francisco in San Francisco, USA and his colleagues show that Olig2+ oligodendrocyte precursor-like glioma cells invade by single-cell vessel co-option and preserve the blood-brain barrier (BBB). Conversely, Olig2-negative glioma cells form dense perivascular collections and promote angiogenesis and BBB breakdown, leading to innate immune cell activation. Experimentally, Olig2 promotes Wnt7b expression, a finding that correlates in human glioma profiling. Targeted Wnt7a/7b deletion or pharmacologic Wnt inhibition blocks Olig2+ glioma single-cell vessel co-option and enhances responses to temozolomide. Finally, Olig2 and Wnt7 become upregulated after anti-VEGF treatment in preclinical models and patients. Thus, glial-encoded pathways regulate distinct glioma-vascular microenvironmental interactions.

Read more, please click https://www.cell.com/cancer-cell/fulltext/S1535-6108(18)30125-9

4. Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression
Immune system defects are at the center of aging and a range of diseases. Here, Chia-Wei Cheng at University of Southern California in Los Angeles, USA and his colleagues show that prolonged fasting reduces circulating IGF-1 levels and PKA activity in various cell populations, leading to signal transduction changes in long-term hematopoietic stem cells (LT-HSCs) and niche cells that promote stress resistance, self-renewal, and lineage-balanced regeneration. Multiple cycles of fasting abated the immunosuppression and mortality caused by chemotherapy and reversed age-dependent myeloid-bias in mice, in agreement with preliminary data on the protection of lymphocytes from chemotoxicity in fasting patients. The proregenerative effects of fasting on stem cells were recapitulated by deficiencies in either IGF-1 or PKA and blunted by exogenous IGF-1. These findings link the reduced levels of IGF-1 caused by fasting to PKA signaling and establish their crucial role in regulating hematopoietic stem cell protection, self-renewal, and regeneration.

Read more, please click https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(14)00151-9

5. Fasting Activates Fatty Acid Oxidation to Enhance Intestinal Stem Cell Function during Homeostasis and Aging
Diet has a profound effect on tissue regeneration in diverse organisms, and low caloric states such as intermittent fasting have beneficial effects on organismal health and age-associated loss of tissue function. The role of adult stem and progenitor cells in responding to short-term fasting and whether such responses improve regeneration are not well studied. Here Maria M. Mihaylova at Whitehead Institute for Biomedical Research in Cambridge, USA and her colleagues show that a 24 hr fast augments intestinal stem cell (ISC) function in young and aged mice by inducing a fatty acid oxidation (FAO) program and that pharmacological activation of this program mimics many effects of fasting. Acute genetic disruption of Cpt1a, the rate-limiting enzyme in FAO, abrogates ISC-enhancing effects of fasting, but long-term Cpt1a deletion decreases ISC numbers and function, implicating a role for FAO in ISC maintenance. These findings highlight a role for FAO in mediating pro-regenerative effects of fasting in intestinal biology, and they may represent a viable strategy for enhancing intestinal regeneration.



Read more, please click https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(18)30163-2

2018年7月16日星期一

The Nobel Prize in Physiology or Medicine 2013

The Nobel Prize in Physiology or Medicine 2013 was awarded jointly to James E. Rothman, Randy W. Schekman and Thomas C. Südhof "for their discoveries of machinery regulating vesicle traffic, a major transport system in our cells".













NobelistBornAffiliation at the time of the award
James E. Rothman3 November 1950, Haverhill, MA, USAYale University, New Haven, CT, USA
Randy W. Schekman30 December 1948, St. Paul, MN, USAUniversity of California, Berkeley, CA, USA, Howard Hughes Medical Institute
Thomas C. Südhof22 December 1955, Göttingen, GermanyStanford University, Stanford, CA, USA, Howard Hughes Medical Institute

Summary


The 2013 Nobel Prize honours three scientists who have solved the mystery of how the cell organizes its transport system. Each cell is a factory that produces and exports molecules. For instance, insulin is manufactured and released into the blood and signaling molecules called neurotransmitters are sent from one nerve cell to another. These molecules are transported around the cell in small packages called vesicles. The three Nobel Laureates have discovered the molecular principles that govern how this cargo is delivered to the right place at the right time in the cell.

Randy Schekman discovered a set of genes that were required for vesicle traffic. James Rothman  unravelled protein machinery that allows vesicles to fuse with their targets to permit transfer of cargo. Thomas Südhof revealed how signals instruct vesicles to release their cargo with precision.

Through their discoveries, Rothman, Schekman and Südhof have revealed the exquisitely precise control system for the transport and delivery of cellular cargo. Disturbances in this system have deleterious effects and contribute to conditions such as neurological diseases, diabetes, and immunological disorders.

More details, please click The 2013 Nobel Prize in Physiology or Medicine.

The Nobel Prize in Physiology or Medicine 2013

The Nobel Prize in Physiology or Medicine 2013 was awarded jointly to James E. Rothman, Randy W. Schekman and Thomas C. Südhof "for their discoveries of machinery regulating vesicle traffic, a major transport system in our cells".













NobelistBornAffiliation at the time of the award
James E. Rothman3 November 1950, Haverhill, MA, USAYale University, New Haven, CT, USA
Randy W. Schekman30 December 1948, St. Paul, MN, USAUniversity of California, Berkeley, CA, USA, Howard Hughes Medical Institute
Thomas C. Südhof22 December 1955, Göttingen, GermanyStanford University, Stanford, CA, USA, Howard Hughes Medical Institute

Summary


The 2013 Nobel Prize honours three scientists who have solved the mystery of how the cell organizes its transport system. Each cell is a factory that produces and exports molecules. For instance, insulin is manufactured and released into the blood and signaling molecules called neurotransmitters are sent from one nerve cell to another. These molecules are transported around the cell in small packages called vesicles. The three Nobel Laureates have discovered the molecular principles that govern how this cargo is delivered to the right place at the right time in the cell.

Randy Schekman discovered a set of genes that were required for vesicle traffic. James Rothman  unravelled protein machinery that allows vesicles to fuse with their targets to permit transfer of cargo. Thomas Südhof revealed how signals instruct vesicles to release their cargo with precision.

Through their discoveries, Rothman, Schekman and Südhof have revealed the exquisitely precise control system for the transport and delivery of cellular cargo. Disturbances in this system have deleterious effects and contribute to conditions such as neurological diseases, diabetes, and immunological disorders.

More details, please click The 2013 Nobel Prize in Physiology or Medicine.

2018年7月12日星期四

The Nobel Prize in Physiology or Medicine 2014

The Nobel Prize in Physiology or Medicine 2014 was divided, one half awarded to John O'Keefe, the other half jointly to May-Britt Moser and Edvard I. Moser "for their discoveries of cells that constitute a positioning system in the brain".













NobelistBornAffiliation at the time of the award
John O'Keefe18 November 1939, New York, NY, USAUniversity College, London, United Kingdom
May-Britt Moser4 January 1963, Fosnavåg, NorwayNorwegian University of Science and Technology (NTNU), Trondheim, Norway
Edvard I. Moser27 April 1962, Ålesund, NorwayNorwegian University of Science and Technology (NTNU), Trondheim, Norway

How do we know where we are? How can we find the way from one place to another? And how can we store this information in such a way that we can immediately find the way the next time we trace the same path? The 2014 year's Nobel Laureates have discovered a positioning system, an "inner GPS" in the brain that makes it possible to orient ourselves in space, demonstrating a cellular basis for higher cognitive function.

More details, please click The 2014 Nobel Prize in Physiology or Medicine.

Structural basis of ubiquitin modification by the Legionella effector SdeA

Content introduction:

  • Pyramidal cell regulation of interneuron survival sculpts cortical networks

  • Cortical direction selectivity emerges at convergence of thalamic synapses

  • Structural basis of ubiquitin modification by the Legionella effector SdeA

  • ANKRD16 prevents neuron loss caused by an editing-defective tRNA synthetase

  • Structure of a volume-regulated anion channel of the LRRC8 family


1. Pyramidal cell regulation of interneuron survival sculpts cortical networks
Complex neuronal circuitries such as those found in the mammalian cerebral cortex have evolved as balanced networks of excitatory and inhibitory neurons. Although the establishment of appropriate numbers of these cells is essential for brain function and behaviour, our understanding of this fundamental process is limited. Here Fong Kuan Wong at King’s College London in London, UK and his colleagues show that the survival of interneurons in mice depends on the activity of pyramidal cells in a critical window of postnatal development, during which excitatory synaptic input to individual interneurons predicts their survival or death. Pyramidal cells regulate interneuron survival through the negative modulation of PTEN signalling, which effectively drives interneuron cell death during this period. Their findings indicate that activity-dependent mechanisms dynamically adjust the number of inhibitory cells in nascent local cortical circuits, ultimately establishing the appropriate proportions of excitatory and inhibitory neurons in the cerebral cortex.

Read more, please click https://www.nature.com/articles/s41586-018-0139-6

2. Cortical direction selectivity emerges at convergence of thalamic synapses
Detecting the direction of motion of an object is essential for our representation of the visual environment. The visual cortex is one of the main stages in the mammalian nervous system in which the direction of motion may be computed de novo. Experiments and theories indicate that cortical neurons respond selectively to motion direction by combining inputs that provide information about distinct spatial locations with distinct time delays. Despite the importance of this spatiotemporal offset for direction selectivity, its origin and cellular mechanisms are not fully understood. Anthony D. Lien at University of California San Diego in La Jolla, USA and his colleagues show that approximately 80 ± 10 thalamic neurons, which respond with distinct time courses to stimuli in distinct locations, excite mouse visual cortical neurons during visual stimulation. The integration of thalamic inputs with the appropriate spatiotemporal offset provides cortical neurons with a primordial bias for direction selectivity. These data show how cortical neurons selectively combine the spatiotemporal response diversity of thalamic neurons to extract fundamental features of the visual world.

Read more, please click https://www.nature.com/articles/s41586-018-0148-5

3. Structural basis of ubiquitin modification by the Legionella effector SdeA
Protein ubiquitination is a multifaceted post-translational modification that controls almost every process in eukaryotic cells. Recently, the Legionella effector SdeA was reported to mediate a unique phosphoribosyl-linked ubiquitination through successive modifications of the Arg42 of ubiquitin (Ub) by its mono-ADP-ribosyltransferase (mART) and phosphodiesterase (PDE) domains. However, the mechanisms of SdeA-mediated Ub modification and phosphoribosyl-linked ubiquitination remain unknown. Here Yanan Dong at Beijing University of Chemical Technology in Beijing, China and his colleagues report the structures of SdeA in its ligand-free, Ub-bound and Ub–NADH-bound states. The structures reveal that the mART and PDE domains of SdeA form a catalytic domain over its C-terminal region. Upon Ub binding, the canonical ADP-ribosyltransferase toxin turn-turn (ARTT) and phosphate-nicotinamide (PN) loops in the mART domain of SdeA undergo marked conformational changes. The Ub Arg72 might act as a ‘probe’ that interacts with the mART domain first, and then movements may occur in the side chains of Arg72 and Arg42 during the ADP-ribosylation of Ub. Their study reveals the mechanism of SdeA-mediated Ub modification and provides a framework for further investigations into the phosphoribosyl-linked ubiquitination process.



Read more, please click https://www.nature.com/articles/s41586-018-0146-7

4. ANKRD16 prevents neuron loss caused by an editing-defective tRNA synthetase
Editing domains of aminoacyl tRNA synthetases correct tRNA charging errors to maintain translational fidelity. A mutation in the editing domain of alanyl tRNA synthetase (AlaRS) in Aarssti mutant mice results in an increase in the production of serine-mischarged tRNAAla and the degeneration of cerebellar Purkinje cells. Here, using positional cloning, My-Nuong Vo at Scripps Research Institute in La Jolla, USA and his colleagues identified Ankrd16, a gene that acts epistatically with the Aarssti mutation to attenuate neurodegeneration. ANKRD16, a vertebrate-specific protein that contains ankyrin repeats, binds directly to the catalytic domain of AlaRS. Serine that is misactivated by AlaRS is captured by the lysine side chains of ANKRD16, which prevents the charging of serine adenylates to tRNAAla and precludes serine misincorporation in nascent peptides. The deletion of Ankrd16 in the brains of Aarssti/sti mice causes widespread protein aggregation and neuron loss. These results identify an amino-acid-accepting co-regulator of tRNA synthetase editing as a new layer of the machinery that is essential to the prevention of severe pathologies that arise from defects in editing.

Read more, please click https://www.nature.com/articles/s41586-018-0137-8

5. Structure of a volume-regulated anion channel of the LRRC8 family
Volume-regulated anion channels are activated in response to hypotonic stress. These channels are composed of closely related paralogues of the leucine-rich repeat-containing protein 8 (LRRC8) family that co-assemble to form hexameric complexes. Here, using cryo-electron microscopy and X-ray crystallography, Dawid Deneka at University of Zurich in Zurich, Switzerland and his colleagues determine the structure of a homomeric channel of the obligatory subunit LRRC8A. This protein conducts ions and has properties in common with endogenous heteromeric channels. Its modular structure consists of a transmembrane pore domain followed by a cytoplasmic leucine-rich repeat domain. The transmembrane domain, which is structurally related to connexin proteins, is wide towards the cytoplasm but constricted on the outside by a structural unit that acts as a selectivity filter. An excess of basic residues in the filter and throughout the pore attracts anions by electrostatic interaction. Their work reveals the previously unknown architecture of volume-regulated anion channels and their mechanism of selective anion conduction.

Read more, please click https://www.nature.com/articles/s41586-018-0134-y

Antibodies as Cell Biological Tools

Monoclonal and polyclonal antibodies are powerful tools for addressing cell biological questions. These immunological reagents can be used to detect and analyze proteins and carbohydrates, characterize the subcellular distribution of proteins, and purify proteins. In addition, when taken up by cells, antibodies can be used as tags to monitor the intracellular pathways of proteins and to inhibit protein activity. These diverse applications of antibody technology have been facilitated by advances in the understanding of the molecular genetics of antibody molecules and their three-dimensional structures. The development of methods for measuring antibody binding activity and for isolating antibodies has contributed to their widespread use and extensive range of applications.

The development of monoclonal antibodies, unique and powerful reagents for detecting and measuring interactions with specific protein epitopes, has revolutionized the use of antibodies in cell biological research. These antibodies are obtained by fusing immune B cells from the spleen with tumor cells to produce hybridomas. Hybridomas each secrete a single type of antibody—the monoclonal antibody—that has precise specificity and often high affinity. Because the cloned hybridoma cell line is immortal, with appropriate care it can be maintained indefinitely and the antibodies it produces can be supplied in essentially limitless quantities. Preparations containing monoclonal antibodies include hybridoma supernatants, ascites fluid from a mouse inoculated with the hybridoma, and purified monoclonal antibody.

Polyclonal antibodies take less effort to prepare than monoclonal antibodies. The process consists simply of immunizing an animal of any one of a variety of species (including goat, horse, rat, mouse, and rabbit) with purified antigen and then, after the animal develops an immune response, isolating antibodies from its serum. Because polyclonal antibodies are essentially a collection of monoclonal antibodies with different epitope specificities and affinities, they are useful for analyses of denatured forms of a protein, for immunoprecipitation and immunoblotting. These types of analyses are often not successful with monoclonal antibodies because the single epitope recognized by the monoclonal antibody preparation may be destroyed during protein denaturation.

The choice of animal species for immunization depends in part on the amount of antiserum required for subsequent experiments. Mice, rats, and guinea pigs yield relatively low volumes of antiserum compared to rabbits and other larger animals. For this reason, rabbits are often the animals of choice. It is often desirable to produce polyclonal antibodies in other species, however, especially when an experiment requires two distinct types of antibodies that recognize different proteins (as is often the case in indirect immunofluorescence assays).



The term "antibody production" has both general and specific meanings. In the broad sense, it refers to the entire process of creating a usable specific antibody, including steps of immunogen preparation, immunization, hybridoma creation, collection, screening, isotyping, purification, and labeling for direct use in a particular method. In the more restricted sense, antibody production refers to the steps leading up to antibody generation but does not include various forms of purifying and labeling the antibody for particular uses.Successful antibody production depends upon careful planning and implementation with respect to several important steps and considerations:
1. Synthesizing or purifying the target antigen (e.g., peptide or hapten);
2. Choosing an appropriate immunogenic carrier protein;
3. Conjugating the antigen and carrier protein to create the immunogen;
4. Immunizing animals using appropriate schedules and adjuvant formulae;
5. Screening serum (or hybridomas) for antibody titer and isotype;
Procedures for generating, purifying and modifying antibodies for use as antigen-specific probes were developed during the 1970s and 1980s and have remained relatively unchanged since Harlow and Lane published their classic Antibodies: A Laboratory Manual in 1988.